CClinicalTrials.gg
TerminatedNCT03036566Updated Jul 25, 2024Results posted

Lithium Disilicate (CAD/CAM) Fixed Partial Dentures (FPD) Clinical Study

An interventional study of Lithium disilicate ceramic (Ivoclar) in Missing Tooth, sponsored by University of Michigan. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-25.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

Why this study was terminated
Loss of funding due to COVID-19
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This investigation will be a clinical trial to study the performance of a high strength ceramic material for bridges to replace missing teeth. The ceramic material has been approved by the FDA for patient treatment. A computer technique will be used to make the bridges. The bridges will be cemented using an adhesive resin cement (MultiLink Automix/Ivoclar). The bridges are planned be evaluated for clinical performance at 6 months, 1 year, 2 years, 3 years, and if funding permits, 4 years, and 5 years. The purpose of the study is to measure how well the high strength bridges function over an extended period of time.

Read the detailed description

The study will be composed of 30 bridges placed in adult patients that have been identified as requiring replacement of a single tooth. All the bridges will be made from the same high strength ceramic material (emaxCAD/Ivoclar) using a computer to make the entire bridge. All the crowns will be cemented using the most current marketed version of the manufacturer's adhesive resin cement (MultiLink Automix/Ivoclar). At each recall appointment an evaluation of the bridge will be completed as well as clinical photographs, an intraoral digital scan, and impression of the bridge. The purpose of the study is to measure how well the high strength bridges function over an extended period of time.

02

Conditions studied

  • Missing Tooth
03

In context

Tooth Loss

224 studies on the registry are indexed under Tooth Loss; 50 are open to participants now.

This study's enrollment of 30 is close to the median of 30 across 166 interventional studies indexed under Tooth Loss.

Browse Tooth Loss studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • missing one anterior or premolar tooth that is appropriate for replacement with a bridge. The second premolar tooth will be the most distal tooth acceptable as a pontic for inclusion in the study.
  • healthy periodontal status for the adjacent abutment teeth with 1:1 crown:root ratio
  • abutment teeth must be asymptomatic prior to treatment
  • Endodontically treated teeth will be acceptable for abutments as long as nonmetallic cores can be placed to retain the FPD since the lithium disilicate will be bonded to the abutments.
  • no more than one bridge will be placed per patient. If a patient presents with more than one missing teeth acceptable for the study, premolar teeth will be included prior to anterior teeth. Each bridge will be three units and include only one missing tooth.

Exclusion criteria

Exclusion Criteria:

  • sensitive abutment teeth
  • teeth with a history of direct or indirect pulp capping procedures
  • patients with significant untreated dental disease to include periodontitis and caries
  • pregnant or lactating women
  • patients with allergies to any material in the study
  • patients unable to return for recall appointments
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Bridge

    Three unit high strength ceramic (lithium disilicate/emaxCAD by Ivoclar) bridges replacing a single tooth.

    Device: Lithium disilicate ceramic (Ivoclar)

Interventions

  • DeviceLithium disilicate ceramic (Ivoclar)

    Three unit high strength ceramic bridges replacing a single tooth.

    Also known as: fixed partial denture

06

What researchers measure

Primary outcomes

  1. Bridge Failure

    Bridge failure includes fracture of the bridge or loss of the bridge requiring placement of a new bridge at any time between delivery and five years.

    Time frame: from delivery of the bridge up to 5 years

Secondary outcomes

  1. Bridge Loss of Retention

    Loss of retention is measured as detachment of the bridge from the teeth without fracture of the bridge requiring recementation of the bridge.

    Time frame: from delivery of the bridge up to 5 years

  2. Number of Bridges Associate With Tooth Sensitivity

    Tooth Sensitivity is evaluated as either "0" if the subject reports that there is NO sensitivity for either tooth with the study bridge, or "1" if the subject reports that there IS tooth sensitivity to hot/cold or biting pressure for either tooth supporting the bridge. The better outcome is to have NO tooth sensitivity.

    Time frame: from delivery of the bridge up to 5 years

  3. Number of Bridges Associated With Margin Staining

    Margin Staining is evaluated as either "0" if there is NO staining at the crown margin where it meets the tooth for either tooth supporting the bridge, or "1" if there IS staining at the crown margin where it meets the tooth for either tooth supporting the bridge. The better outcome is to have NO margin staining.

    Time frame: from delivery of the bridge up to 5 years

07

Results

Posted Apr 5, 2023

Participant flow

Participant flow — Overall Study
MilestoneBridge
Started30
Completed27
Not completed3
Withdrew: Lost to follow-up3

Outcome measures

PrimaryBridge Failure

Bridge failure includes fracture of the bridge or loss of the bridge requiring placement of a new bridge at any time between delivery and five years.

Time frame:
from delivery of the bridge up to 5 years
Reported as:
Number · number of bridges
Bridge Failure
number of bridgesBridge
Bridge Failure2
SecondaryBridge Loss of Retention

Loss of retention is measured as detachment of the bridge from the teeth without fracture of the bridge requiring recementation of the bridge.

Time frame:
from delivery of the bridge up to 5 years
Reported as:
Number · number of bridges
Bridge Loss of Retention
number of bridgesBridge
Bridge Loss of Retention0
SecondaryNumber of Bridges Associate With Tooth Sensitivity

Tooth Sensitivity is evaluated as either "0" if the subject reports that there is NO sensitivity for either tooth with the study bridge, or "1" if the subject reports that there IS tooth sensitivity to hot/cold or biting pressure for either tooth supporting the bridge. The better outcome is to have NO tooth sensitivity.

Time frame:
from delivery of the bridge up to 5 years
Reported as:
Number · number of bridges
Number of Bridges Associate With Tooth Sensitivity
number of bridgesBridge
Number of Bridges Associate With Tooth Sensitivity0
SecondaryNumber of Bridges Associated With Margin Staining

Margin Staining is evaluated as either "0" if there is NO staining at the crown margin where it meets the tooth for either tooth supporting the bridge, or "1" if there IS staining at the crown margin where it meets the tooth for either tooth supporting the bridge. The better outcome is to have NO margin staining.

Time frame:
from delivery of the bridge up to 5 years
Reported as:
Number · number of bridges
Number of Bridges Associated With Margin Staining
number of bridgesBridge
Number of Bridges Associated With Margin Staining3

Adverse events

Collected over 5 years. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Bridge0/30 (0%)0/30 (0%)0/30 (0%)

Baseline characteristics

Age, Customized
Age, Customized(Participants)Bridge
Count of participants0
Sex: Female, Male
Sex: Female, Male(Participants)Bridge
Female19
Male11
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Bridge
08

Study locations

1 site
  • University of Michigan
    Ann Arbor, Michigan 48109, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · May 23, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03036566
Lead sponsor
University of Michigan
Collaborators
Ivoclar Vivadent AG
Responsible party
Dennis J. Fasbinder, DDS (Clinical Professor, University of Michigan) — Principal investigator
First posted
Jan 30, 2017
Start date
Mar 2014
Primary completion
Mar 5, 2020
Completion
Mar 5, 2020
Results posted
Apr 5, 2023
Last update
Jul 25, 2024

Study contacts

Dennis J Fasbinder, DDS
principal investigator · University of Michigan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion